Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

11 mars 2025 18h12 HE | Source: Robbins LLP

EPIX Shareholders Have an Opportunity to Lead the Class Action Against ESSA Pharma Inc. – Contact Shareholder Rights Law Firm Robbins LLP for Information

Robbins LLP is Investigating Allegations that ESSA Pharma Inc. (EPIX) Misled Investors Regarding the Efficacy of its Drug Candidate Masofaniten
14 févr. 2025 17h33 HE | Source: Robbins LLP

EPIX STOCK NEWS: EPIX Shareholders with Large Losses Should Contact Robbins LLP for Information About the Class Action Lawsuit Against Essa Pharma Inc.

Robbins LLP is Investigating Allegations that ESSA Pharma Inc. (EPIX) Misled Investors Regarding the Efficacy of its Drug Candidate Masofaniten
28 janv. 2025 15h14 HE | Source: Robbins LLP

EPIX Investor Notice: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Against ESS Pharma Inc.

Robbins LLP is Investigating Allegations that ESSA Pharma Inc. (EPIX) Misled Investors Regarding the Efficacy of its Drug Candidate Masofaniten